Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-06-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
MuteButton is indicated for the treatment of permanent intractable subjective tinnitus. The study is intended to show the efficacy of MuteButton treatment in alleviating tinnitus. The objective of the study will be to determine the impact of acoustic and tactile multi-modal neuromodulation on symptoms of permanent intractable tinnitus as measured by objective and subjective measures including Minimum Masking Level (MML), Tinnitus Loudness Masking (Tinnitus Loudness Masking), Tinnitus Handicap Inventory (THI) and Visual Analogue Scale (VAS).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1 Tinnitus Alleviation Via Sensory Substitution
NCT02570048
Auditory-somatosensory Stimulation to Alleviate Tinnitus
NCT02974543
Customized Acoustic Stimulation for the Treatment of Tinnitus
NCT01487447
Mechanism Research of Tinnitus Based on Electroencephalogram and Acoustic Therapy Intervention
NCT04449237
Acoustic and Electrical Stimulation for the Treatment of Tinnitus
NCT03511807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The efficacy of the intervention will be assessed by the change in several psychoascoutic assessments assessed at each of the 6 follow up visits with the investigators at 2 week intervals.
The Psychoacoustic Assessment will include:
Tinnitus Matching (Pitch) - symptom severity Tinnitus Loudness Matching (TLM ) - symptom severity Minimum Masking Level (MML) - symptom severity
Questionnaires to be utilised will include:
Visual Analogue Scale (VAS) - symptom severity Tinnitus Handicap Inventory (THI) - symptom severity
A primary endpoint at 16 weeks is to show a reduction in THI, and psychoacoustic assessment will be established. Secondary endpoint will include reduction in MML, and psychoacoustic assessment will be established.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MuteButton sensory stimulation device
Participants will be asked to use the Mutebutton, neuro-modulation device every day for 60 minutes for 12 weeks. Use of the device involves placing a 'lollipop' type sensor on the tongue and wearing earphones. The participant will hear "pink noise" through the earphones and will receive neuro-stimulation through the sensor. The participant will not feel any discomfort whilst using the MuteButton device.
MuteButton sensory stimulation device
Participants are asked to use the MuteButton daily for 30-40 minutes. They receive 'pink noise' through headphones and transcutaneous stimulation on the tongue using a 'lollipop' sensor that sits on the anterior section (tip) of the tongue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MuteButton sensory stimulation device
Participants are asked to use the MuteButton daily for 30-40 minutes. They receive 'pink noise' through headphones and transcutaneous stimulation on the tongue using a 'lollipop' sensor that sits on the anterior section (tip) of the tongue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering from subjective intractable tinnitus
* Tinnitus \> 6 months
* Tinnitus associated with an age or noise related sensory-neural hearing loss
* Have sound English reading, comprehension and written skills
* Able and willing to participate in the study for the 16 weeks duration
* Informed consent
Exclusion Criteria
* Meniere's Disease - due to the fluctuating hearing loss patients normally present with
* Hyperacusis - to avoid further aggravation of sensitivity of sound
* Current medical legal cases regarding tinnitus or hearing - in order to avoid any conflict of interest
* Undergoing any treatment for tinnitus - in order to accurately measure the independent effect of the intervention.
* Pacemakers - due to potential magnetic interference.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hermitage clinic, Lucan, Ireland
UNKNOWN
National University of Ireland, Maynooth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Hubert Lim
Prof. Pearlmutter
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pearlmutter1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.